Company Filing History:

17 out of 854

Roussel Uclaf

patents

Hoechst Marion Roussel

patents

4. 1 out of 832,680

Other

patents

Years Active: 1985-2007

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7285619 - Echinocandin derivatives, their method of preparation and their application as anti-fungal agents (2007-10-23),

2. 7192920 - Derivatives of echinocandine, their preparation process and their use as antifungals (2007-03-20),

3. 7160983 - Echinocandin derivatives, their method of preparation and their application as anti-fungal agents (2007-01-09),

4. 7022669 - Echinocandin derivatives, method for preparing same and application as antifungal agents (2006-04-04),

5. 7005417 - Echinocandin derivatives, method for preparing same and use as antifungal agents (2006-02-28),

6. 6677429 - Echinocandin derivatives, preparation method and application as anti-fungal agents (2004-01-13),

7. 6313305 - Cephalosporins (2001-11-06),

8. 5883248 - Cephalosporins (1999-03-16),

9. 5763617 - Cephalosporins (1998-06-09),

10. 5728828 - Cephalosporins (1998-03-17),

11. 5712266 - Cephalosporins (1998-01-27),

12. 5710147 - 7-benzyloxyimino-cephalosporins (1998-01-20),

13. 5587372 - Cephalosporins (1996-12-24),

14. 5455238 - Cephalosporins (1995-10-03),

15. 5141952 - Heterocyclic dicarboxylic acids (1992-08-25),

Title: A Spotlight on Patrick Fauveau: Innovator in Antifungal Agents

Introduction

Patrick Fauveau, a prominent inventor based in Livry Gargan, France, has made significant contributions to the field of pharmaceuticals, specifically in the development of antifungal agents. With an impressive portfolio of 25 patents, Fauveau has been at the forefront of innovation, aiming to improve therapeutic solutions and combat fungal infections.

Latest Patents

Fauveau's latest work includes notable patents like "Echinocandin derivatives, their method of preparation and their application as anti-fungal agents." This invention focuses on compounds that showcase antifungal properties, specifically those of formula (I), where substituents are meticulously defined for optimal efficacy. Another significant patent, "Derivatives of echinocandine, their preparation process and their use as antifungals," emphasizes the preparation process and the various isomer forms of the compounds that exhibit robust antifungal activity.

Career Highlights

Throughout his career, Fauveau has worked with leading pharmaceutical companies such as Roussel Uclaf and Aventis Pharma. His experiences at these organizations have paved the way for groundbreaking advancements within the pharmaceutical industry, particularly in antifungal research and development.

Collaborations

Patrick Fauveau's journey in innovation has been marked by fruitful collaborations with esteemed colleagues like Jozsef Aszodi and Jean-Francois Chantot. These partnerships have facilitated an exchange of ideas and expertise, enhancing the quality and impact of their collective research in the field of medicinal chemistry.

Conclusion

In summary, Patrick Fauveau stands out as a significant contributor to pharmaceutical innovations aimed at addressing fungal infections. Through his numerous patents and collaborations, he continues to shape the industry with his pioneering work, affirming his status as a key inventor in the realm of antifungal agents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.